Health ministry: Enforcing strict quality compliance for tainted pharma companies

The ministry of health has assured the members of parliament in particular and public in general that the drugs companies that flouted USFDA norms in past, are under the scanner of regulator


The US Food and Drug Administration (FDA) has taken certain regulatory actions in respect of violations or deviations of US FDA regulations applicable in that country in the cases of the following Indian pharmaceutical companies Ranbaxy Laboratories, Wockhardt, Hospira Healthcare India and RPG Life Sciences.

The union minister of health and family welfare, Ghulam Nabi Azad stated in the Parliament on August 30, 2013, "The Drugs Controller General (India) [DCG(I)] has taken appropriate measures to ensure that the said firms manufacture drugs in compliance with the standards and Good Manufacturing Practices prescribed for them under the Drugs and Cosmetics Rules, 1945 through the system of inspections and testing of drugs."

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email